HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Morbidity characteristics of patients with congenital insensitivity to pain with anhidrosis (CIPA).

AbstractBACKGROUND:
Congenital insensitivity to pain with anhidrosis (CIPA) is a congenital autonomic sensory neuropathy. In southern Israel, there are many patients with this disease. We here tried to characterize the different infections acquired by children with CIPA.
METHODS:
We collected all the available data about CIPA patients in southern Israel in the year 1991-2005, including the lesion types, area in the body where the infection occurs, and the treatment given.
RESULTS:
The current study included 30 children with CIPA, out of 44 known CIPA patients in southern Israel (68.2%). A total of 382 different episodes of infections, fever, orthopedic lesions, and jaw and mouth lesions led our patients to our outpatient clinic or resulted in hospitalization.
CONCLUSION:
We found that children with CIPA mainly have infections of the skin and skeleton, and that the most frequent pathogen is Staphylococcus aureus. We also found that a fair amount of these pathogens are resistant to conventional treatment regimens.
AuthorsYariv Fruchtman, Zvi H Perry, Jacov Levy
JournalJournal of pediatric endocrinology & metabolism : JPEM (J Pediatr Endocrinol Metab) Vol. 26 Issue 3-4 Pg. 325-32 ( 2013) ISSN: 0334-018X [Print] Germany
PMID23744299 (Publication Type: Journal Article)
Topics
  • Adolescent
  • Arthritis, Infectious (epidemiology)
  • Bacterial Infections (epidemiology)
  • Child
  • Child, Preschool
  • Female
  • Fever (epidemiology)
  • Hereditary Sensory and Autonomic Neuropathies (epidemiology)
  • Humans
  • Infant
  • Infant, Newborn
  • Israel (epidemiology)
  • Male
  • Morbidity
  • Self-Injurious Behavior (epidemiology)
  • Skin Ulcer (epidemiology)
  • Staphylococcal Infections (epidemiology)
  • Stomatognathic Diseases (epidemiology)
  • Wound Healing

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: